Cordon-Cardo C - Search Results

1

Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer.

Seager CM, Puzio-Kuter AM, Patel T, Jain S, Cordon-Cardo C, Mc Kiernan J, Abate-Shen C. Seager CM, et al. Cancer Prev Res (Phila). 2009 Dec;2(12):1008-14. doi: 10.1158/1940-6207.CAPR-09-0169. Epub 2009 Dec 1. Cancer Prev Res (Phila). 2009. PMID: 19952358 Free PMC article.

2

Inactivation of p53 and Pten promotes invasive bladder cancer.

Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, Matos T, Shen MM, Cordon-Cardo C, Abate-Shen C. Puzio-Kuter AM, et al. Genes Dev. 2009 Mar 15;23(6):675-80. doi: 10.1101/gad.1772909. Epub 2009 Mar 4. Genes Dev. 2009. PMID: 19261747 Free PMC article.

3

Mouse models of human bladder cancer as a tool for drug discovery.

Seager C, Puzio-Kuter AM, Cordon-Cardo C, McKiernan J, Abate-Shen C. Seager C, et al. Curr Protoc Pharmacol. 2010 Jun;Chapter 14:Unit14.14. doi: 10.1002/0471141755.ph1414s49. Curr Protoc Pharmacol. 2010. PMID: 22294368 Free PMC article.

4

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.

Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C. Kinkade CW, et al. J Clin Invest. 2008 Sep;118(9):3051-64. doi: 10.1172/JCI34764. J Clin Invest. 2008. PMID: 18725989 Free PMC article.

5

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.

Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM. Wosnitzer MS, et al. Cancer. 2012 Jan 15;118(2):358-64. doi: 10.1002/cncr.26278. Epub 2011 Jun 29. Cancer. 2012. PMID: 21717438 Free article.

6

Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy.

Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylack DP, Benson MC, McKiernan JM, Cordon-Cardo C. Wosnitzer MS, et al. J Urol. 2011 Nov;186(5):2094-100. doi: 10.1016/j.juro.2011.06.051. Epub 2011 Sep 23. J Urol. 2011. PMID: 21944130

7

Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma.

Puzio-Kuter AM, Laddha SV, Castillo-Martin M, Sun Y, Cordon-Cardo C, Chan CS, Levine AJ. Puzio-Kuter AM, et al. Cell Death Differ. 2015 Nov;22(11):1785-91. doi: 10.1038/cdd.2015.27. Epub 2015 Mar 27. Cell Death Differ. 2015. PMID: 25822339 Free PMC article.

8

Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder.

Cheng J, Huang H, Pak J, Shapiro E, Sun TT, Cordon-Cardo C, Waldman FM, Wu XR. Cheng J, et al. Cancer Res. 2003 Jan 1;63(1):179-85. Cancer Res. 2003. PMID: 12517796

9

Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.

Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP. Ma L, et al. Cancer Res. 2007 Aug 1;67(15):7106-12. doi: 10.1158/0008-5472.CAN-06-4798. Cancer Res. 2007. PMID: 17671177

10

Molecular pathways of urothelial development and bladder tumorigenesis.

Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C. Castillo-Martin M, et al. Urol Oncol. 2010 Jul-Aug;28(4):401-8. doi: 10.1016/j.urolonc.2009.04.019. Urol Oncol. 2010. PMID: 20610278 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

646 results

Search Page

Filters